Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06928649

Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies

Led by University Hospital, Antwerp · Updated on 2025-04-15

600

Participants Needed

1

Research Sites

124 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Antwerp

Lead Sponsor

U

Universiteit Antwerpen

Collaborating Sponsor

AI-Summary

What this Trial Is About

In order to better determine which therapy is best for patiënts which present with organ falure during the course of their stay in the intesive care unit (ICU) , one has to determine which underlying mechanism is causing this organ falure. We will determine levels of so called "biomarkers" for ferroptosis (a mechan ism of iron-related cell death) in the peripheral blood and biological fluids of criticaly ill patients admitted to the ICU with a catastrrophy (severe infection, trauma ...) . Why ? If it turns out that this ferroptosis plays a role in the ocurrence of organ failure in the critially ill, this will lead to new therapies in the future as drugs become more and more available which can influene this biochemical "pahway". of iron-relatd death.

CONDITIONS

Official Title

Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Admitted to the ICU of UZA
  • Critically ill and expected to stay in the ICU for more than 48 hours (mostly patients admitted for sepsis, trauma, hemorrhagic shock, neurological catastrophe)
  • Have an arterial line in place for blood sampling
Not Eligible

You will not qualify if you...

  • Refusal of consent by patient or closest relative
  • Postoperative patients after major surgery where prolonged ICU stay is not expected (e.g., elective cardiac surgery)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital Antwerp

Edegem, Belgium, 2650

Actively Recruiting

Loading map...

Research Team

T

Tom Stroobants, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here